Milkhaus Laboratory Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Milkhaus Laboratory Inc.
Beech Tree raises series B to complete Phase II antiviral trials
Beech Tree Labs has closed an over-subscribed series B round where it raised $7 million from undisclosed investors. The funds will be used to finish two Phase II trials currently in progress with Beech's lead drug candidate, BTL-TML, for influenza and recurrent oral herpes.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Milkhaus Veterinary Products Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice